Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Trial Phase 3 Completed March 22, 2017

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Trial Phase 3 Completed March 22, 2017

Caffeine as a Therapy for Parkinson's Disease

Trial Phase 3 Completed March 21, 2017

A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

Trial Phase 1 Completed March 20, 2017

Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease

Trial Phase 1 Completed March 20, 2017

Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment

Trial N/A Completed March 16, 2017

Dance Exercise as Novel Complementary Therapy for Parkinson's Disease

Trial N/A Completed March 15, 2017

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

Trial Phase 3 Completed March 14, 2017

Extended Long-Term Safety Study of KW-6500

Trial Phase 3 Completed March 14, 2017

Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Trial Phase 4 Completed March 9, 2017

Translation and Validation of BELA-p-K for QoL Evaluation in PD Patients

Trial N/A Completed March 7, 2017

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500

Trial Phase 3 Completed March 2, 2017

Motor, Non-motor and Genetic Determinants of Progression in Parkinson's Disease: A Mexican Multicenter Cohort Study

Trial N/A Completed March 2, 2017

Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease

Trial Phase 2 Completed Feb. 28, 2017

Movement Disorder Quantification Algorithm Development

Trial N/A Completed Feb. 22, 2017

Remote Access to Care, Everywhere, for Parkinson Disease

Trial N/A Completed Feb. 22, 2017

Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder

Trial N/A Terminated Feb. 22, 2017

Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease

Trial Phase 3 Completed Feb. 22, 2017

Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)

Trial N/A Withdrawn Feb. 22, 2017

Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Trial Phase 2 Completed Feb. 22, 2017